Side effects of commonly used glaucoma medications: comparison of tolerability, chance of discontinuation, and patient satisfaction

Abstract

Background To compare the tolerability of commonly prescribed topical glaucoma medications by determining frequency and bother of side effects, patient satisfaction with their medication, and the chance of discontinuation of eye drops. Methods The tolerability of topical glaucoma medication was studied in glaucoma patients from nine hospitals. The frequency and severity of side effects was investigated together with patient satisfaction with the medication and the probability to change medication due to reported side effects. To register side effects of topical glaucoma medication, patients were requested to fill in a questionnaire based on "the Comparison of Ophthalmic Medications for Tolerability" (COMTOL) questionnaire supplemented with items based on the most frequently observed and severe side effects.Results The number of patients responding was 3,333 (87%). Most patients (79%) were satisfied with their eye medication. The median score for ocular side effects was 58 on a scale ranging from 0 to 320. The probability that medication would be changed by the ophthalmologist at the next visit due to reported side effects occurring since the patients' last or last but one visit to the ophthalmologist was 9%. The most frequently prescribed drugs were timolol, latanoprost, and the fixed combinations of dorzolamide/ timolol (Cosopt®) and latanoprost/timolol (Xalcom®). Only small differences in tolerability were found between these drugs. Conclusions The tolerability of timolol, latanoprost, and the fixed combinations of latanoprost/timolol (Xalcom®) and dorzolamide/timolol (Cosopt®) seem to be comparable. Patients are satisfied with their glaucoma medication and have a low chance of discontinuation of eye drops due to side effects.

Targeted Delivery of Antiglaucoma Drugs to the Supraciliary Space Using Microneedles

“…51,52 As a result, eye drops must be given at least daily and there can be side effects from systemic delivery of the poorly absorbed drug. 53,54 This study introduced the idea of targeting the ciliary body by injection into the adjacent supraciliary space. We accessed this space, located just a few hundred micrometers below the conjunctival surface, by using a hollow microneedle designed to be just long enough to penetrate to the base of the sclera.…”

The relationship between visual field loss in glaucoma and health-related quality-of-life

“…Side effects of current medications were explored with two lists of 16 typical side effects from pressure-lowering eye-drops. 6 One list asked how often side effect occurred, ranging from never (0) to every day (5). The other asked how bothered the patient was by the side effect, ranging from 'not bothered' (0) to 'extremely bothered' (4).…”

Role of fixed-combination brinzolamide 1%/timolol 0.5% in the treatment of elevated intraocular pressure in open-angle glaucoma and ocular hypertension

“…A recent meta-analysis confirmed that these 2 types of glaucoma therapies produce equivalent efficacy 3. In a large study (N = 3333) of patients taking glaucoma medications, the majority (79%) reported that they were satisfied with their eye drops; however, nearly 1 in 10 patients (9%) were likely to have their medication changed at their next visit due to side effects 4. Each hypotensive agent has a characteristic side effect profile, but fixed-combination products as a group have a number of advantages over the instillation of 2 individual drugs 5.…”